Related Experiment Videos
Spermicidal activity of Magainins: in vitro and in vivo studies
K V Reddy1, S K Shahani, P K Meherji
1Department of Immunology, Institute for Research in Reproduction (ICMR), Bombay, India.
Abstract:
Spermicidal efficacy of two synthetic antimicrobial peptides, viz. Magainin-A (Mag-A) and Magainin-G (Mag-G), have been studied under in vitro condition using rat and human spermatozoa. The data showed that sperm motility was inhibited with various concentrations of Magainins at different intervals ranging from 20 to 480 seconds as compared to controls. The minimum concentration of Mag-A required to immobilize spermatozoa (40-60 x 10(6)/ml of saline) within 20 seconds was found to be 100 micrograms in rat and 200 micrograms in human. The action of Mags on sperm motility was observed to be dose-dependent. The activity of Mag-A was significantly (P < 0.05) higher than Mag-G (P < 0.05). The in vivo studies in rats indicated that Mag-A when applied intravaginally, on the day of estrus, at the dose level of 200 micrograms, for five consecutive estrous cycles, induced no abnormalities either in the length of estrous cycle or in morphology of vaginal epithelial cells. When Mag-A was applied intravaginally before mating on the proestrusestrus day, complete arrest of sperm motility with 200 micrograms concentration was observed and none of these treated females conceived after the mating. In view of these facts, it is suggested that Mag-A, having anti-bacterial, anti-viral, anti-fungal and spermicidal activities, could be a potent vaginal contraceptive.
Insights
Synthetic antimicrobial peptides, Magainin-A (Mag-A) and Magainin-G (Mag-G), demonstrated significant spermicidal efficacy. Mag-A proved more potent, showing dose-dependent inhibition of sperm motility and potential as a vaginal contraceptive.
Area of Science:
- Biochemistry
- Reproductive Biology
- Microbiology
Background:
- Synthetic antimicrobial peptides (AMPs) are being explored for various therapeutic applications.
- The spermicidal potential of AMPs remains an area of active research.
- Magainin-A (Mag-A) and Magainin-G (Mag-G) are synthetic AMPs with known antimicrobial properties.
Purpose of the Study:
- To evaluate the in vitro and in vivo spermicidal efficacy of Mag-A and Mag-G.
- To determine the minimum effective concentrations and dose-dependent effects of these peptides on sperm motility.
- To assess the safety and contraceptive potential of Mag-A in a rodent model.
Main Methods:
- In vitro assessment of sperm motility inhibition using rat and human spermatozoa exposed to varying concentrations of Mag-A and Mag-G.
- In vivo studies in rats involving intravaginal application of Mag-A during estrus cycles and before mating.
- Evaluation of estrous cycle length and vaginal epithelial cell morphology in treated rats.
Main Results:
- Both Mag-A and Mag-G inhibited sperm motility in a dose-dependent manner and within varying time intervals (20-480 seconds).
- Mag-A demonstrated higher efficacy than Mag-G, with minimum effective concentrations of 100 µg (rat) and 200 µg (human) to immobilize sperm within 20 seconds.
- In vivo application of Mag-A (200 µg) did not induce abnormalities in estrous cycles or vaginal cells and resulted in complete contraception when applied before mating.
Conclusions:
- Mag-A exhibits significant in vitro and in vivo spermicidal activity.
- Mag-A's potent spermicidal action, coupled with its safety profile in rats, suggests its potential as a novel vaginal contraceptive agent.
- Further research into Mag-A's contraceptive capabilities is warranted.